Among all the cases studies, 77(84.6%) were of hepatoce- llular carcinoma, 9(9.9%) of cholangiocarcinoma, 2(2.2%)of mixed cell car- cinoma, and 3(3.3%;) of hepatoblastoma.
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。